SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000897069-23-001044
Filing Date
2023-08-01
Accepted
2023-08-01 17:10:16
Documents
1
Period of Report
2022-12-06

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 27586
  Complete submission text file 0000897069-23-001044.txt   28926
Mailing Address 2575 W. BELLFORT SUITE 333 HOUSTON TX 77054
Business Address
Priebe Waldemar (Reporting) CIK: 0001678516 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39126 | Film No.: 231132728

Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Issuer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations